S.B. 133 Summary

• Prohibits health insuring corporations and public employee benefit plans from providing less favorable coverage for orally administered cancer medications compared to intravenously administered or injected cancer medications, including restrictions on copayments, deductibles, coverage limits, and prior authorization requirements.

• Requires health insurers offering coverage for non-self-injectable medications or medications requiring immediate pre-administration compounding to either allow enrollees to obtain medications from retail pharmacies (including specialty and mail-order pharmacies) or provide the option of direct delivery by mail or commercial shipment.

• Applies coverage requirements to individual and group health insuring corporation policies and public employee benefit plans delivered, issued, or renewed in Ohio on or after the effective date.

• Amends section 1739.05 to require multiple employer welfare arrangements operating group self-insurance programs to comply with the new health insurance coverage standards for cancer medications and non-self-injectable drugs.

• Establishes definitions for "dangerous drug," "pharmacy," "non-self-injectable medication," and "retail seller" by reference to existing state pharmacy law.